Jul 01, 2022
The North East Innovation Lab has played a key role in a successful study to develop a new biosensor which could be used in Covid-19 diagnostic tests.
Read More
May 30, 2022
New combined tests deliver highly accurate point-of-care detection for SARS-CoV-2, Flu A, Flu B and RSV – boosting infection control in hospitals and speeding patient access to urgent care.
Read More
May 26, 2022
New multiplex panel can detect SARS CoV 2, Flu A Flu B RSV at the Point of Need and can deliver accurate PCR results in approximately 30 minutes.
Read More
May 19, 2022
BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, today announced that the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium has chosen it to supply biosamples for the Neurofilament as a Blood-Based Biomarker of Neurodegeneration in Familial Frontotemporal Degeneration (FTD) Project.
Read More
May 16, 2022
LSG has recently completed a move to new, larger facilities in Sandy, Bedfordshire. The facilities will offer expanded manufacturing capabilities available in new cleanroom suites equipped to GMP standards.
Read More
Apr 27, 2022
According to a recent Lancet report, Antimicrobial Resistance (AMR) isn’t a pandemic in waiting, its already here. AMR infections are estimated to cause 700,000 deaths each year globally. That figure is predicted to rise to 10 million, alongside a cumulative cost of $1 trillion, by 2050 if no action is taken. That’s a hundred times greater than the global economic threat of covid-19.
Read More
Apr 26, 2022
AMLo Biosciences Ltd (AMLo), an innovative medical device company spun out of Newcastle University specialising in the early detection of skin cancers, is pleased to announce it has secured significant further investment totalling £2.45m.
Read More
Apr 13, 2022
BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, today announced that it has appointed Jennifer Murphy as Senior Vice President of Global Commercial Operations. In her new role, Jennifer will be responsible for building and growing the global commercial programs for all BioIVT’s product lines and services
Read More
Apr 13, 2022
The North East Innovation Lab, originally established as part of the region’s integrated Covid hub, has received an investment of £1.4 million to continue work on assessing and evaluating the next generation of diagnostic tests
Read More
Apr 07, 2022
Transaction expands BioIVT’s donor network and increases its capacity to provide fresh whole blood, plasma, serum, and red blood cells for drug and diagnostic development
Read More
Page 1 of 14 FirstPrevious [1]